The State of Texas Top Legal Officer Takes Legal Action Against Tylenol Makers Regarding Autism Claims

Legal Proceedings
The Texas Attorney General, who supports former President Trump who is running for US Senate, claimed pharmaceutical manufacturers of withholding the risks of acetaminophen

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of acetaminophen, claiming the corporations hid potential risks that the pain reliever posed to children's cognitive development.

The court filing follows thirty days after Donald Trump publicized an unproven link between taking Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in young ones.

Paxton is suing the pharmaceutical giant, which previously sold the medication, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "misled consumers by making money from discomfort and promoting medication without regard for the potential hazards."

The company states there is no credible evidence connecting acetaminophen to autism.

"These manufacturers lied for decades, knowingly endangering millions to line their pockets," Paxton, a Republican, said.

The manufacturer commented that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the health of women and children in America."

On its online platform, Kenvue also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a established connection between consuming paracetamol and autism."

Groups acting on behalf of doctors and health professionals concur.

ACOG has declared paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to address discomfort and elevated temperature, which can create serious health risks if ignored.

"In multiple decades of research on the consumption of paracetamol in gestation, zero credible investigations has definitively established that the use of paracetamol in any trimester of pregnancy results in neurodevelopmental disorders in offspring," the organization commented.

This legal action cites recent announcements from the previous government in arguing the medication is allegedly unsafe.

Last month, the former president raised alarms from medical authorities when he instructed pregnant women to "fight like hell" not to consume Tylenol when ill.

The US Food and Drug Administration then published an announcement that doctors should think about restricting the consumption of acetaminophen, while also declaring that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would identify the cause of autism in a limited time.

But experts cautioned that discovering a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism is a form of lifelong neurodivergence and condition that influences how persons experience and relate to the world, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - claims Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the corporations "remove any promotional materials" that states acetaminophen is safe for expectant mothers.

This legal action mirrors the grievances of a collection of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in recently.

The court rejected the lawsuit, declaring studies from the family's specialists was not conclusive.

Jonathan Gallagher
Jonathan Gallagher

A passionate writer and digital nomad sharing experiences from global travels and tech innovations.